Glycotope Biotechnology offers GMP-compliant biotechnological contract manufacturing based on animal cell culture systems and perfusion fermentation technologies. These services are supported by research and development in immunology, cell biology, molecular biology and protein chemistry. Based on the GlycoExpress technology of Glycotope GmbH, Berlin, we can offer the development and production of pharmaceutical proteins and antibodies in human cell lines with optimised glycosylation pattern.
Our R&D departments work closely together with the scientists at the German Cancer Research Centre and the University in Heidelberg. In these fields our significant experiences gained over time from a large number contract research projects are of major advantage for our clients.
Additional R&D services offered include transfection, clone selection and cell line development, MCB and WCB establishment and characterisation, product characterisation, validation studies and process optimisation.
Glycotope Biotechnology complies with all criteria specified by the European Pharmaceutical legislation, the European Pharmacopoeia, and the EU and ICH guidelines.